InfoRetriever/InfoPOEMS – trial ends Aug. 25, 2007
InfoPOEMs® highlight the progression of clinically-applicable evidence, one study at a time. InfoRetriever® uniquely enables rapid point-of-care access to the best available filtered, graded, synopsized evidence and evidence-derived tools.
InfoRetriever®, by presenting the best evidence and not just expert opinion, provides clinicians the information needed to make the best clinical decisions. By focusing on “Patient-Oriented Evidence that Matters” (POEMs), it avoids the wrong decisions too often associated with expert opinion in recent years. For example – doxazosin for hypertension, vitamin E for heart disease, beta-carotene to prevent cancer, arthroscopic surgery for osteoarthritis of the knee, hormone replacement therapy to prevent heart disease, patching corneal abrasions, using encainide for post-infarction arrhythmias, and sleeping infants on their sides or stomach
– were all recommended by experts yet all worsened patient outcomes.
InfoPOEMs® are synopses of new evidence, relevant to patient care, from a continuous review, grading, and critical appraisal of 1200+ studies published monthly in 100 journals. Each study is filtered for relevance and then for validity, using criteria from the Centre for Evidence-Based Medicine (Oxford). About 1 in 40 studies qualify as an InfoPOEM, and 20-30 InfoPOEMs are identified
monthly.
Take a tour of InfoRetriever at http://www.infopoems.com/product/tour.cfm
Please send your comments to Patrick Ellis
Erika says
Well said.